Intech Investment Management LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 36.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 211,490 shares of the healthcare conglomerate’s stock after purchasing an additional 56,872 shares during the period. UnitedHealth Group comprises 0.8% of Intech Investment Management LLC’s holdings, making the stock its 16th biggest holding. Intech Investment Management LLC’s holdings in UnitedHealth Group were worth $77,634,000 at the end of the most recent quarter.
Several other institutional investors have also added to or reduced their stakes in UNH. BlackRock Inc. grew its stake in shares of UnitedHealth Group by 4.6% during the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after buying an additional 3,395,530 shares during the last quarter. State Street Corp lifted its stake in shares of UnitedHealth Group by 0.7% during the 2nd quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate’s stock worth $18,966,555,000 after acquiring an additional 301,081 shares during the last quarter. Bank of America Corp DE boosted its holdings in UnitedHealth Group by 21.8% during the 1st quarter. Bank of America Corp DE now owns 11,713,684 shares of the healthcare conglomerate’s stock valued at $3,169,606,000 after acquiring an additional 2,097,859 shares during the period. Fisher Asset Management LLC grew its position in UnitedHealth Group by 19.2% in the 3rd quarter. Fisher Asset Management LLC now owns 10,829,637 shares of the healthcare conglomerate’s stock valued at $3,975,343,000 after acquiring an additional 1,747,368 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its stake in UnitedHealth Group by 6.1% in the second quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate’s stock worth $4,449,317,000 after purchasing an additional 616,723 shares during the period. Institutional investors own 87.86% of the company’s stock.
Analyst Ratings Changes
A number of analysts have recently issued reports on UNH shares. Bank of America reissued a “buy” rating and set a $450.00 target price on shares of UnitedHealth Group in a research note on Monday, July 20th. KeyCorp reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday, October 14th. UBS Group reissued an “outperform” rating on shares of UnitedHealth Group in a research report on Tuesday, October 13th. JPMorgan Chase & Co. upped their target price on shares of UnitedHealth Group from $516.00 to $524.00 and gave the stock an “overweight” rating in a research note on Friday, October 16th. Finally, Wells Fargo & Company reduced their target price on shares of UnitedHealth Group from $526.00 to $487.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 27th. Twenty analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $463.93.
Check Out Our Latest Stock Report on UNH
UnitedHealth Group Stock Performance
Shares of UnitedHealth Group stock opened at $407.62 on Monday. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62. The stock’s fifty day moving average price is $391.36 and its 200-day moving average price is $365.66. The firm has a market cap of $365.23 billion, a P/E ratio of 23.28, a P/E/G ratio of 1.47 and a beta of 0.51. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.66.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.14 by $0.55. The company had revenue of $112.72 billion for the quarter, compared to analysts’ expectations of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The firm’s quarterly revenue was down .4% on a year-over-year basis. During the same period in the prior year, the business earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be paid a dividend of $2.32 per share. The ex-dividend date is Monday, December 7th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 53.00%.
Insider Transactions at UnitedHealth Group
In related news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.19% of the stock is currently owned by insiders.
Top UnitedHealth Group Stories
These are some of the UNH stories that stood out recently:
- Positive Sentiment: Optum Rx reported higher operating earnings in the third quarter of 2026 despite lower prescription volumes. Biosimilar adoption and operating efficiencies helped offset pressure, demonstrating the segment’s ability to grow profitability amid membership challenges. Article: Can UNH’s Optum Rx Sustain Profit Growth as Prescription Volumes Fall?
- Positive Sentiment: ETF flows were supportive: 51 ETFs bought UNH while nine sold shares on Nov. 11, for reported net ETF buying of $86.8 million. Article: UnitedHealth Sees $86.8 Million in Net ETF Buying
- Neutral Sentiment: A technical analysis described UNH as consolidating, with neutral momentum and thin volume, suggesting no strong near-term signal from trading activity. Article: UnitedHealth Stock Price Prediction
About UnitedHealth Group
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
See Also
- Five stocks we like better than UnitedHealth Group
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
